| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA538318
Max Phase: Preclinical
Molecular Formula: C13H18ClNO3
Molecular Weight: 235.28
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COC(=O)CN(C)C(C)C(=O)c1ccccc1.Cl
Standard InChI: InChI=1S/C13H17NO3.ClH/c1-10(14(2)9-12(15)17-3)13(16)11-7-5-4-6-8-11;/h4-8,10H,9H2,1-3H3;1H
Standard InChI Key: HWTCGRMQXWTNNV-UHFFFAOYSA-N
Associated Targets(non-human)
GABA transporter 97 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 235.28 | Molecular Weight (Monoisotopic): 235.1208 | AlogP: 1.36 | #Rotatable Bonds: 5 |
| Polar Surface Area: 46.61 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.39 | CX LogP: 1.62 | CX LogD: 1.61 |
| Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.57 | Np Likeness Score: -0.70 |
References
| 1. Héja L, Kovács I, Szárics E, Incze M, Temesváriné-Major E, Dörnyei G, Peredy-Kajtár M, Gács-Baitz E, Szántay C, Kardos J.. (2004) Novel secoergoline derivatives inhibit both GABA and glutamate uptake in rat brain homogenates: synthesis, in vitro pharmacology, and modeling., 47 (23): [PMID:15509161] [10.1021/jm040809c] |
Source
Source(1):